Abstract

PLANNING AND EVALUATION MSKCC relies on both the counsel of outside advisors, represented by its Board of Scientific Consultants (BSC), the guidance of its Board of Overseers and Managers, as well as the many internal planning processes to support the review and evaluation of the research programs and core facilities at the Center. During the current grant period, the Center has continued to expand its laboratory and patientoriented research programs to meet its planned strategic goals. In addition, a new PhD degree-granting school was established, after an extensive evaluation and review process. At its annual meetings, the BSC has reviewed a number of research areas including: Computational Biology, Proteomics, Experimental Therapeutics, Health Disparities and Inclusion of Underrepresented Minorities in Clinical Trials, Stem Cell Research, Aging and Cancer, and Molecular Imaging.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA008748-47
Application #
8375196
Study Section
Subcommittee G - Education (NCI)
Project Start
2012-01-09
Project End
2013-12-31
Budget Start
2012-01-09
Budget End
2012-12-31
Support Year
47
Fiscal Year
2012
Total Cost
$5,653,316
Indirect Cost
$5,608,032

  Institution

Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065

  Publications

Shamay, Yosi; Shah, Janki; I??k, Mehtap et al. (2018) Quantitative self-assembly prediction yields targeted nanomedicines. Nat Mater 17:361-368
Drilon, Alexander; Laetsch, Theodore W; Kummar, Shivaani et al. (2018) Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children. N Engl J Med 378:731-739
Cracchiolo, Jennifer R; Xu, Bin; Migliacci, Jocelyn C et al. (2018) Patterns of recurrence in oral tongue cancer with perineural invasion. Head Neck 40:1287-1295
Sanchez, Elisa; Huse, Morgan (2018) Spatial and Temporal Control of T Cell Activation Using a Photoactivatable Agonist. J Vis Exp :
Brufsky, Adam M; Dickler, Maura N (2018) Estrogen Receptor-Positive Breast Cancer: Exploiting Signaling Pathways Implicated in Endocrine Resistance. Oncologist 23:528-539
Varughese, Tilly; Taur, Ying; Cohen, Nina et al. (2018) Serious Infections in Patients Receiving Ibrutinib for Treatment of Lymphoid Cancer. Clin Infect Dis 67:687-692
Pacheco, Sarai; Maldonado-Linares, Andros; Marcet-Ortega, Marina et al. (2018) ATR is required to complete meiotic recombination in mice. Nat Commun 9:2622
Marzouk, Karim; Tin, Amy; Liu, Nick et al. (2018) The natural history of large renal masses followed on observation. Urol Oncol 36:362.e17-362.e21
Shickh, Salma; Clausen, Marc; Mighton, Chloe et al. (2018) Evaluation of a decision aid for incidental genomic results, the Genomics ADvISER: protocol for a mixed methods randomised controlled trial. BMJ Open 8:e021876
Mobley, David L; Bannan, Caitlin C; Rizzi, Andrea et al. (2018) Escaping Atom Types in Force Fields Using Direct Chemical Perception. J Chem Theory Comput 14:6076-6092

Showing the most recent 10 out of 8799 publications